Surprisingly, we also observed an extensive GCN2 phosphorylation in pulmonary vascular ECs in patients with IPAH, demonstrating the clinical relevance of GCN2 activation in the pathogenesis of PAH. This evidence concerns the gene EIF2AK4 and pulmonary arterial hypertension.